{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:55:31Z","timestamp":1781646931773,"version":"3.54.5"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Aberrant expression levels of miR-760 and miR-1973 were observed in different solid tumors; however, their expression levels in breast cancer (BC) remain unclear. This study aimed to evaluate their expression levels, assess their relationship with the clinicopathological features, and explore their molecular mechanisms using bioinformatic analysis. MiRNAs\u2019 expression levels and CA 15.3 concentration were measured in 130 patients and 30 healthy controls. Databases were used to predict their target genes, functional enrichment analyses were carried out, and PPI network was constructed. Additionally, the Kaplan-Meier (KM) plotter online database was utilized for survival analysis. Both miRNAs\u2019 levels were significantly overexpressed in BC patients and more pronounced in the early stage. Further, the diagnostic abilities of miR-760 and miR-1973 were superior in discriminating BC patients than CA 15.3. These miRNAs were associated with increased susceptibility to BC. Based on bioinformatic analysis, 4 hub genes were identified and implicated in significant signaling pathways in BC. KM plotter demonstrated that BC patients with overexpressed miR-760 had shorter overall survival. In conclusion, this study provides novel insights into the clinical utility of miR-760 and miR-1973 as non-invasive biomarkers for BC and sheds light on their important contribution to BC pathogenesis.<\/jats:p>","DOI":"10.1038\/s41598-026-44175-3","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T03:46:34Z","timestamp":1775015194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insight into the potential significance of miR-760 and miR-1973 in breast cancer: a comprehensive analysis"],"prefix":"10.1038","volume":"16","author":[{"given":"Sara A.","family":"Kamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid E.","family":"Zahran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham A. A.","family":"Elshimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"4","key":"44175_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.15406\/mojbm.2017.01.00019","volume":"1","author":"LT Angahar","year":"2017","unstructured":"Angahar, L. T. An overview of breast cancer epidemiology, risk factors, pathophysiology, and cancer risks reduction. MOJ Biol. Med. 1 (4), 92\u201396 (2017).","journal-title":"MOJ Biol. Med."},{"issue":"7","key":"44175_CR2","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.1002\/jcp.26379","volume":"233","author":"SH Jafari","year":"2018","unstructured":"Jafari, S. H. et al. Breast cancer diagnosis: Imaging techniques and biochemical markers. J. Cell. Physiol. 233 (7), 5200\u20135213 (2018).","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"44175_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10147-008-0773-3","volume":"13","author":"M Uehara","year":"2008","unstructured":"Uehara, M. et al. Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15\u2009\u2013\u20093 (CA 15\u2009\u2013\u20093) in breast cancer. Int. J. Clin. Oncol. 13 (5), 447\u2013451 (2008).","journal-title":"Int. J. Clin. Oncol."},{"issue":"11","key":"44175_CR4","doi-asserted-by":"publisher","first-page":"8538","DOI":"10.1002\/jcp.26850","volume":"233","author":"L Jamali","year":"2018","unstructured":"Jamali, L. et al. Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers. J. Cell. Physiol. 233 (11), 8538\u20138550 (2018).","journal-title":"J. Cell. Physiol."},{"issue":"36","key":"44175_CR5","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.2174\/0929867323666160818093854","volume":"23","author":"H Mirzaei","year":"2016","unstructured":"Mirzaei, H. et al. Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives. Curr. Med. Chem. 23 (36), 4135\u20134150 (2016).","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"44175_CR6","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/jcp.25793","volume":"233","author":"S Gholamin","year":"2018","unstructured":"Gholamin, S. et al. GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma. J. Cell. Physiol. 233 (2), 866\u2013879 (2018).","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"44175_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/cgt.2016.48","volume":"23","author":"L Saadatpour","year":"2016","unstructured":"Saadatpour, L. et al. Glioblastoma: exosome and microRNA as novel diagnosis biomarkers. Cancer Gene Ther. 23 (12), 415\u2013418 (2016).","journal-title":"Cancer Gene Ther."},{"issue":"10","key":"44175_CR8","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1002\/jcb.26042","volume":"118","author":"M Keshavarzi","year":"2017","unstructured":"Keshavarzi, M. et al. Molecular imaging and oral cancer diagnosis and therapy. J. Cell. Biochem. 118 (10), 3055\u20133060 (2017).","journal-title":"J. Cell. Biochem."},{"issue":"10","key":"44175_CR9","doi-asserted-by":"publisher","first-page":"13414","DOI":"10.3390\/ijms131013414","volume":"13","author":"J Tang","year":"2012","unstructured":"Tang, J., Ahmad, A. & Sarkar, F. H. The role of microRNAs in breast cancer migration, invasion and metastasis. Int. J. Mol. Sci. 13 (10), 13414\u201313437 (2012).","journal-title":"Int. J. Mol. Sci."},{"key":"44175_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-007-5590-1_1","volume":"774","author":"TA Farazi","year":"2013","unstructured":"Farazi, T. A., Hoell, J. I., Morozov, P. & Tuschl, T. MicroRNAs in human cancer. Adv. Exp. Med. Biol. 774, 1\u201320 (2013).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"44175_CR11","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1261\/rna.1034808","volume":"14","author":"LX Yan","year":"2008","unstructured":"Yan, L. X. et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14 (11), 2348\u20132360 (2008).","journal-title":"RNA"},{"issue":"19","key":"44175_CR12","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.3390\/ijms20194940","volume":"20","author":"HY Loh","year":"2019","unstructured":"Loh, H. Y. et al. The regulatory role of MicroRNAs in breast cancer. Int. J. Mol. Sci. 20 (19), 4940 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"44175_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1476-4598-13-142","volume":"13","author":"P Parrella","year":"2014","unstructured":"Parrella, P. et al. Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients. Mol. Cancer. 13, 142 (2014).","journal-title":"Mol. Cancer"},{"issue":"2","key":"44175_CR14","first-page":"gmr15027350","volume":"15","author":"N Wang","year":"2016","unstructured":"Wang, N., Chen, P., Huang, L. P. & Wang, T. Z. Prognostic significance of microRNA-10b overexpression in breast cancer: a meta-analysis. Genet. Mol. Res. 15 (2), gmr15027350 (2016).","journal-title":"Genet. Mol. Res."},{"issue":"2","key":"44175_CR15","doi-asserted-by":"publisher","first-page":"e0118647","DOI":"10.1371\/journal.pone.0118647","volume":"10","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis. PLoS One. 10 (2), e0118647 (2015).","journal-title":"PLoS One"},{"issue":"11","key":"44175_CR16","doi-asserted-by":"publisher","first-page":"e0260327","DOI":"10.1371\/journal.pone.0260327","volume":"16","author":"A Amirfallah","year":"2021","unstructured":"Amirfallah, A. et al. Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways. PLoS One. 16 (11), e0260327 (2021).","journal-title":"PLoS One"},{"issue":"10","key":"44175_CR17","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1245\/s10434-017-5984-2","volume":"24","author":"SY Kim","year":"2017","unstructured":"Kim, S. Y. et al. Clinical relevance of microRNA expressions in breast cancer validated using the cancer genome atlas (TCGA). Ann. Surg. Oncol. 24 (10), 2943\u20132949 (2017).","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"44175_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4110\/in.2011.11.3.135","volume":"11","author":"TY Ha","year":"2011","unstructured":"Ha, T. Y. MicroRNAs in human diseases: from cancer to cardiovascular disease. Immune Netw. 11 (3), 135\u2013154 (2011).","journal-title":"Immune Netw."},{"issue":"9","key":"44175_CR19","doi-asserted-by":"publisher","first-page":"e44398","DOI":"10.1371\/journal.pone.0044398","volume":"7","author":"Q Wang","year":"2012","unstructured":"Wang, Q. et al. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS One. 7 (9), e44398 (2012).","journal-title":"PLoS One"},{"issue":"23","key":"44175_CR20","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.1158\/1078-0432.CCR-12-3186","volume":"19","author":"T Iwaya","year":"2013","unstructured":"Iwaya, T. et al. Contrasting expression patterns of histone mRNA and microRNA 760 in patients with gastric cancer. Clin. Cancer Res. 19 (23), 6438\u20136449 (2013).","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"44175_CR21","doi-asserted-by":"publisher","first-page":"18385","DOI":"10.1007\/s11356-017-1138-0","volume":"25","author":"C Yan","year":"2018","unstructured":"Yan, C. et al. MiR-760 suppresses non-small cell lung cancer proliferation and metastasis by targeting ROS1. Environ. Sci. Pollut Res. Int. 25 (19), 18385\u201318391 (2018).","journal-title":"Environ. Sci. Pollut Res. Int."},{"issue":"3","key":"44175_CR22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ygyno.2016.09.010","volume":"143","author":"Y Liao","year":"2016","unstructured":"Liao, Y. et al. MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression. Gynecol. Oncol. 143 (3), 655\u2013663 (2016).","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"44175_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/cgt.2017.23","volume":"24","author":"X Guo","year":"2017","unstructured":"Guo, X., Xiao, H., Guo, S., Dong, L. & Chen, J. Identification of breast cancer mechanism based on weighted gene coexpression network analysis. Cancer Gene Ther. 24 (8), 333\u2013341 (2017).","journal-title":"Cancer Gene Ther."},{"issue":"4","key":"44175_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.7150\/ijbs.12777","volume":"12","author":"L Boo","year":"2016","unstructured":"Boo, L. et al. MiRNA transcriptome profiling of spheroid-enriched cells with cancer stem cell properties in human breast MCF-7 Cell Line. Int. J. Biol. Sci. 12 (4), 427\u2013445 (2016).","journal-title":"Int. J. Biol. Sci."},{"key":"44175_CR25","doi-asserted-by":"publisher","first-page":"e3551","DOI":"10.7717\/peerj.3551","volume":"5","author":"L Boo","year":"2017","unstructured":"Boo, L. et al. Phenotypic and microRNA transcriptomic profiling of the MDA-MB-231 spheroid-enriched CSCs with comparison of MCF-7 microRNA profiling dataset. Peer J. 5, e3551 (2017).","journal-title":"Peer J."},{"issue":"14","key":"44175_CR26","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.7150\/jca.37842","volume":"11","author":"VA Valera","year":"2020","unstructured":"Valera, V. A., Parra-Medina, R., Walter, B. A., Pinto, P. & Merino, M. J. MicroRNA Expression Profiling in Young Prostate Cancer Patients. J. Cancer. 11 (14), 4106\u20134114 (2020).","journal-title":"J. Cancer"},{"issue":"5","key":"44175_CR27","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1158\/1078-0432.CCR-12-2726","volume":"19","author":"S Suryawanshi","year":"2013","unstructured":"Suryawanshi, S. et al. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin. Cancer Res. 19 (5), 1213\u20131224 (2013).","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"44175_CR28","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.humpath.2014.01.013","volume":"45","author":"E Munari","year":"2014","unstructured":"Munari, E. et al. Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Hum. Pathol. 45 (6), 1130\u20131138 (2014).","journal-title":"Hum. Pathol."},{"issue":"6\u20137","key":"44175_CR29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10585-017-9863-9","volume":"34","author":"M Rammer","year":"2017","unstructured":"Rammer, M. et al. MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma. Clin. Exp. Metastasis. 34 (6\u20137), 431\u2013440 (2017).","journal-title":"Clin. Exp. Metastasis"},{"issue":"5","key":"44175_CR30","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s10517-017-3873-0","volume":"163","author":"KA Fomicheva","year":"2017","unstructured":"Fomicheva, K. A., Knyazev, E. N. & Mal\u2019tseva, D. V. hsa-miR-1973 MicroRNA is Significantly and Differentially Expressed in MDA-MB-231 Cells of Breast Adenocarcinoma and Xenografts Derived from the Tumor. Bull. Exp. Biol. Med. 163 (5), 660\u2013662 (2017).","journal-title":"Bull. Exp. Biol. Med."},{"issue":"8","key":"44175_CR31","doi-asserted-by":"publisher","first-page":"e104870","DOI":"10.1371\/journal.pone.0104870","volume":"9","author":"Q Li","year":"2014","unstructured":"Li, Q. et al. Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel. PLoS One. 9 (8), e104870 (2014).","journal-title":"PLoS One"},{"issue":"4","key":"44175_CR32","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/carcin\/bgs030","volume":"33","author":"Z Hu","year":"2012","unstructured":"Hu, Z. et al. Serum microRNA profiling and breast cancer risk: the use of miR-484\/191 as endogenous controls. Carcinogenesis 33 (4), 828\u2013834 (2012).","journal-title":"Carcinogenesis"},{"issue":"4","key":"44175_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (4), 402\u2013408 (2001).","journal-title":"Methods"},{"issue":"3","key":"44175_CR34","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gy\u00f6rffy","year":"2010","unstructured":"Gy\u00f6rffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1809 patients. Breast Cancer Res. Treat. 123 (3), 725\u2013731 (2010).","journal-title":"Breast Cancer Res. Treat."},{"issue":"6472","key":"44175_CR35","doi-asserted-by":"publisher","first-page":"eaav1741","DOI":"10.1126\/science.aav1741","volume":"366","author":"SE McGeary","year":"2019","unstructured":"McGeary, S. E. et al. The biochemical basis of microRNA targeting efficacy. Science 366 (6472), eaav1741 (2019).","journal-title":"Science"},{"issue":"D1","key":"44175_CR36","doi-asserted-by":"publisher","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","volume":"50","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 50 (D1), D222\u2013D230 (2022).","journal-title":"Nucleic Acids Res."},{"key":"44175_CR37","doi-asserted-by":"publisher","first-page":"W148","DOI":"10.1093\/nar\/gkad283","volume":"51(W1)","author":"S Tastsoglou","year":"2023","unstructured":"Tastsoglou, S. et al. DIANA-microT 2023: including predicted targets of virally encoded miRNAs. Nucleic Acids Res. 51(W1), W148\u2013W153 (2023).","journal-title":"Nucleic Acids Res."},{"key":"44175_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer, G. et al. The GeneCards Suite: From gene data mining to disease genome sequence analyses. Curr. Protoc. Bioinf. 54, 1\u201333 (2016).","journal-title":"Curr. Protoc. Bioinf."},{"issue":"D1","key":"44175_CR39","doi-asserted-by":"publisher","first-page":"D833","DOI":"10.1093\/nar\/gkw943","volume":"45","author":"J Pi\u00f1ero","year":"2017","unstructured":"Pi\u00f1ero, J. et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 45 (D1), D833\u2013D839 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"44175_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4 (1), 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"issue":"1","key":"44175_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. K. E. G. G. Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"44175_CR42","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3390\/diagnostics13061142","volume":"13","author":"D Mishra","year":"2023","unstructured":"Mishra, D. et al. Demystifying the role of prognostic biomarkers in breast cancer through integrated transcriptome and pathway enrichment analyses. Diagnostics (Basel). 13 (6), 1142 (2023).","journal-title":"Diagnostics (Basel)"},{"key":"44175_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omto.2022.03.004","volume":"25","author":"X Huang","year":"2022","unstructured":"Huang, X. et al. CCL18 promotes breast cancer progression by exosomal miR-760 activation of ARF6\/Src\/PI3K\/Akt pathway. Mol. Ther. Oncolytics. 25, 1\u201315 (2022).","journal-title":"Mol. Ther. Oncolytics"},{"issue":"5","key":"44175_CR44","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.2353\/ajpath.2010.090837","volume":"176","author":"L Cicatiello","year":"2010","unstructured":"Cicatiello, L. et al. Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. Am. J. Pathol. 176 (5), 2113\u20132130 (2010).","journal-title":"Am. J. Pathol."},{"issue":"8","key":"44175_CR45","doi-asserted-by":"publisher","first-page":"e22167","DOI":"10.1002\/jbt.22167","volume":"32","author":"T Tian","year":"2018","unstructured":"Tian, T. et al. MicroRNA-760 inhibits doxorubicin resistance in hepatocellular carcinoma through regulating notch1\/Hes1-PTEN\/Akt signaling pathway. J. Biochem. Mol. Toxicol. 32 (8), e22167 (2018).","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"44175_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1158\/1078-0432.CCR-13-1024","volume":"20","author":"K Jones","year":"2014","unstructured":"Jones, K., Nourse, J. P., Keane, C., Bhatnagar, A. & Gandhi, M. K. Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma. Clin. Cancer Res. 20 (1), 253\u2013264 (2014).","journal-title":"Clin. Cancer Res."},{"key":"44175_CR47","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.semcancer.2019.06.002","volume":"59","author":"S Revathidevi","year":"2019","unstructured":"Revathidevi, S. & Munirajan, A. K. Akt in cancer: Mediator and more. Semin Cancer Biol. 59, 80\u201391 (2019).","journal-title":"Semin Cancer Biol."},{"issue":"11","key":"44175_CR48","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.bbamcr.2011.06.002","volume":"1813","author":"G Tzivion","year":"2011","unstructured":"Tzivion, G., Dobson, M. & Ramakrishnan, G. FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. Biochim Biophys. Acta. 1813 (11), 1938\u20131945 (2011).","journal-title":"Biochim Biophys. Acta"},{"issue":"4","key":"44175_CR49","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrm2871","volume":"11","author":"SJ Shattil","year":"2010","unstructured":"Shattil, S. J., Kim, C. & Ginsberg, M. H. The final steps of integrin activation: the end game. Nat. Rev. Mol Cell. Biol. 11 (4), 288\u2013300 (2010).","journal-title":"Nat. Rev. Mol Cell. Biol"},{"issue":"2","key":"44175_CR50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2015.05.009","volume":"364","author":"N Shao","year":"2015","unstructured":"Shao, N. et al. Interleukin-8 upregulates integrin \u03b23 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K\/Akt\/NF-\u03baB pathway. Cancer Lett. 364 (2), 165\u2013172 (2015).","journal-title":"Cancer Lett."},{"issue":"3","key":"44175_CR51","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/35060120","volume":"3","author":"WB Kiosses","year":"2001","unstructured":"Kiosses, W. B., Shattil, S. J., Pampori, N. & Schwartz, M. A. Rac recruits high-affinity integrin \u03b1v\u03b23 to lamellipodia in endothelial cell migration. Nat. Cell. Biol. 3 (3), 316\u2013320 (2001).","journal-title":"Nat. Cell. Biol."},{"key":"44175_CR52","doi-asserted-by":"publisher","first-page":"752604","DOI":"10.3389\/fonc.2021.752604","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Dai, J., Zeng, Y., Guo, J. & Lan, J. E3 ubiquitin ligases in breast cancer metastasis: A systematic review of pathogenic functions and clinical implications. Front. Oncol. 11, 752604 (2021).","journal-title":"Front. Oncol."},{"issue":"3","key":"44175_CR53","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10549-019-05506-3","volume":"179","author":"K Kyker-Snowman","year":"2020","unstructured":"Kyker-Snowman, K. et al. TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties. Breast Cancer Res. Treat. 179 (3), 631\u2013642 (2020).","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"44175_CR54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.cytogfr.2012.06.004","volume":"23","author":"H Hondermarck","year":"2012","unstructured":"Hondermarck, H. Neurotrophins and their receptors in breast cancer. Cytokine Growth Factor. Rev. 23 (3), 357\u2013365 (2012).","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"1","key":"44175_CR55","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13046-022-02314-4","volume":"41","author":"S Trouvilliez","year":"2022","unstructured":"Trouvilliez, S. et al. Direct interaction of TrkA\/CD44v3 is essential for NGF-promoted aggressiveness of breast cancer cells. J. Exp. Clin. Cancer Res. 41 (1), 110 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"29","key":"44175_CR56","doi-asserted-by":"publisher","first-page":"17724","DOI":"10.1074\/jbc.R115.667931","volume":"290","author":"Q Jiang","year":"2015","unstructured":"Jiang, Q. & Greenberg, R. A. Deciphering the BRCA1 tumor suppressor network. J. Biol. Chem. 290 (29), 17724\u201317732 (2015).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"44175_CR57","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng0495-444","volume":"9","author":"ME Thompson","year":"1995","unstructured":"Thompson, M. E., Jensen, R. A., Obermiller, P. S., Page, D. L. & Holt, J. T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet. 9 (4), 444\u2013450 (1995).","journal-title":"Nat. Genet."},{"key":"44175_CR58","doi-asserted-by":"publisher","first-page":"e0184385","DOI":"10.1371\/journal.pone.0184385","volume":"12","author":"AM Mahmoud","year":"2017","unstructured":"Mahmoud, A. M. et al. BRCA1 protein expression and subcellular localization in primary breast cancer: Automated digital microscopy analysis of tissue microarrays. PLoS One. 12, e0184385 (2017).","journal-title":"PLoS One"},{"issue":"8","key":"44175_CR59","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/sj.bjc.6600863","volume":"88","author":"JA Fraser","year":"2003","unstructured":"Fraser, J. A. et al. A role for BRCA1 in sporadic breast cancer. Br. J. Cancer. 88 (8), 1263\u20131270 (2003).","journal-title":"Br. J. Cancer"},{"issue":"3","key":"44175_CR60","first-page":"513","volume":"18","author":"R Yoshida","year":"2001","unstructured":"Yoshida, R., Kimura, N., Harada, Y. & Ohuchi, N. The loss of E-cadherin, a and b-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Int. J. Oncol. 18 (3), 513\u2013520 (2001).","journal-title":"Int. J. Oncol."},{"issue":"1","key":"44175_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10549-011-1499-x","volume":"128","author":"DM Li","year":"2011","unstructured":"Li, D. M. & Feng, Y. M. Signaling mechanism of cell adhesion molecules in breast cancer metastasis: Potential therapeutic targets. Breast Cancer Res. Treat. 128 (1), 7\u201321 (2011).","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"44175_CR62","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.3892\/ol.2016.4274","volume":"11","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. CDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer. Oncol. Lett. 11 (4), 2635\u20132643 (2016).","journal-title":"Oncol. Lett."},{"issue":"2","key":"44175_CR63","first-page":"1659","volume":"16","author":"L Yang","year":"2018","unstructured":"Yang, L. et al. Significance and prognosis of epithelial-cadherin expression in invasive breast carcinoma. Oncol. Lett. 16 (2), 1659\u20131665 (2018).","journal-title":"Oncol. Lett."},{"issue":"8","key":"44175_CR64","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nrm882","volume":"3","author":"A Bretscher","year":"2002","unstructured":"Bretscher, A., Edwards, K. & Fehon, R. G. ERM proteins and merlin: integrators at the cell cortex. Nat. Rev. Mol. Cell. Biol. 3 (8), 586\u2013599 (2002).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"3","key":"44175_CR65","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1023\/B:HIJO.0000032354.94213.69","volume":"35","author":"R Marhaba","year":"2004","unstructured":"Marhaba, R. & Z\u00f6ller, M. CD44 in cancer progression: adhesion, migration and growth regulation. J. Mol. Histol. 35 (3), 211\u2013231 (2004).","journal-title":"J. Mol. Histol."},{"issue":"11","key":"44175_CR66","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/jcp.2005.026906","volume":"58","author":"GMK Tse","year":"2005","unstructured":"Tse, G. M. K. et al. CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast. J. Clin. Pathol. 58 (11), 1185\u20131188 (2005).","journal-title":"J. Clin. Pathol."},{"issue":"2","key":"44175_CR67","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ncb1681","volume":"10","author":"Q Huang","year":"2008","unstructured":"Huang, Q. et al. The microRNAs miR-373 and miR-520c promote tumor invasion and metastasis. Nat. Cell. Biol. 10 (2), 202\u2013210 (2008).","journal-title":"Nat. Cell. Biol."},{"issue":"6","key":"44175_CR68","first-page":"7239","volume":"16","author":"D Sun","year":"2018","unstructured":"Sun, D. et al. Prognostic role of miR-760 in hepatocellular carcinoma. Oncol. Lett. 16 (6), 7239\u20137244 (2018).","journal-title":"Oncol. Lett."},{"issue":"45","key":"44175_CR69","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.3748\/wjg.v25.i45.6619","volume":"25","author":"L Ge","year":"2019","unstructured":"Ge, L. et al. MicroRNA-760 acts as a tumor suppressor in gastric cancer development via inhibiting G-protein-coupled receptor kinase interacting protein-1 transcription. World J. Gastroenterol. 25 (45), 6619\u20136633 (2019).","journal-title":"World J. Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44175-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44175-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44175-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:17:13Z","timestamp":1781644633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44175-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44175"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44175-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This work followed the Declaration of Helsinki guidelines. Ethics Committee and Institutional Review Board of National Cancer Institute, Cairo University, Cairo, Egypt, has approved this study (IRB approval code# 202101-04-02001).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that participants provided informed consent for publication of these data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"10994"}}